An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.

about

An effective conjugation strategy for designing short peptide-based HIV-1 fusion inhibitors.

Item

http://www.wikidata.org/entity/Q42050970

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@en

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@nl

type

Item

label

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@en

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@nl

prefLabel

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@en

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@nl

P1476

An effective conjugation strat ...... based HIV-1 fusion inhibitors.

@en

P2093

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Guodong Liang

http://www.w3.org/2001/XMLSchema#string

Huihui Chong

http://www.w3.org/2001/XMLSchema#string

Huixin Wang

http://www.w3.org/2001/XMLSchema#string

Keliang Liu

http://www.w3.org/2001/XMLSchema#string

Siqi Cheng

http://www.w3.org/2001/XMLSchema#string

Xifeng Jiang

http://www.w3.org/2001/XMLSchema#string

Yuxian He

http://www.w3.org/2001/XMLSchema#string

P2860

Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1

Core structure of gp41 from the HIV envelope glycoprotein

Hydrocarbon-stapled peptides: principles, practice, and progress

Antagonists of protein-protein interactions.

Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.

Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.

Design, synthesis, and biological evaluation of highly potent small molecule-peptide conjugates as new HIV-1 fusion inhibitors.

Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket

Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combination.

Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

P304

7875-7882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6OB01334A

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27454320

http://www.w3.org/2001/XMLSchema#string